Next Article in Journal
Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study
Next Article in Special Issue
Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant
Previous Article in Journal
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
Previous Article in Special Issue
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens
 
 
Article

Article Versions Notes

Vaccines 2022, 10(8), 1169; https://doi.org/10.3390/vaccines10081169
Action Date Notes Link
article pdf uploaded. 22 July 2022 13:52 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1169/pdf-vor
article xml file uploaded 25 July 2022 08:07 CEST Original file -
article xml uploaded. 25 July 2022 08:07 CEST Update -
article pdf uploaded. 25 July 2022 08:07 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1169/pdf-vor
article html file updated 25 July 2022 08:08 CEST Original file -
article xml file uploaded 25 July 2022 08:41 CEST Update -
article xml uploaded. 25 July 2022 08:41 CEST Update https://www.mdpi.com/2076-393X/10/8/1169/xml
article pdf uploaded. 25 July 2022 08:41 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1169/pdf
article html file updated 25 July 2022 08:43 CEST Update https://www.mdpi.com/2076-393X/10/8/1169/html
Back to TopTop